GMP Cell Banking Services Market
Cell banking involves storing of cells of specific genome for the purpose of future use in a product or medicinal needs. Mammalian cells, microbial cells, insect cell lines, yeast cells, avian cells, and stem cells are some of the cells that are stored in cell banks for various purposes. Mammalian cells are isolated from specific tissues such as skin, liver, and glands for production of vaccines and various proteins.
Statistics:
The global GMP cell banking services market is estimated to account for US$ 1,326.8 Mn in terms of value by the end of 2027.
Global GMP Cell Banking Services Market:ย Drivers
Increasing funding for R&D in rare diseases is expected to boost growth of the global GMP cell banking services market over the forecast period. For instance, the U.S. Food and Drug Administration (FDA) funds research in rare diseases through congressionally mandated programs such as the Orphan Products Grants Program that supports natural history studies and clinical trials for rare diseases.
๐๐จ ๐ ๐๐ญ ๐๐จ๐ซ๐ ๐๐ฎ๐ฌ๐ข๐ง๐๐ฌ๐ฌ ๐๐ญ๐ซ๐๐ญ๐๐ ๐ข๐๐ฌ ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ @ https://www.coherentmarketinsights.com/insight/request-sample/3634
Moreover, establishment ofย stem cell bankingย resource centers is also expected to aid in growth of the market. For instance, in March 2020, Stemlife Berhad, a cord blood bank in Malaysia, started a Stem Cell Banking Resource Center in Jerudong Park Medical Center, Brunei.
North America region held dominant position in the global GMP cell banking services market in 2019, accounting for 45.9%ย share in terms of value, followed by 2027.
Global GMP Cell Banking Services Market:ย Restraintsย
Stringent regulatory requirements are expected to hinder growth of the global GMP cell banking services market. Quality of the master and working cell banks must be monitored and confirmed on a continuous basis to justify the continuation of the production processes. The data collected from these analytical tests is a regulatory requirement for maintaining the biologic license and distribution of marketed product. The European Medicines Agency (EMA) and the U.S. FDA, in collaboration with other regulatory agencies worldwide, formed the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH), which set forth guidelines for good manufacturing practices. Specifically, ICH guidelines Q5, Q6 and Q7 are applicable to cell banks used in production processes.
Moreover, high costs of services due to nature of material is also expected to limit growth of the market. The costs involved in GMP cell banking services are considerably high, due to the complex processes involved in generation, storage, maintenance, and testing of GMP cell banks and expanses in regulatory adherence.
Global GMP Cell Banking Services Market: Opportunities
Several pharmaceutical and biotechnology companies are increasingly seeking full service in the form of global partners that can be outsourced the entire manufacturing process. This in turn is expected to offer lucrative growth opportunities for players in the market.
Moreover, focus on fast growing emerging markets is also expected to aid in growth of the market. There has been a shift from investment in R&D and technology, especially in the healthcare industry, from North America and Europe to Asia Pacific. Developing economies such as India have ample skilled labor and qualified manpower at affordable costs, thereby increasing the scope for outsourcing of biotech projects.
Biopharmaceutical Companies segment in the global GMP cell banking services market was valued at US$ 315.4 Mn in 2019 and is expected to reach US$ 993.8 Mn by 2027 at a CAGR of 15.4% during the forecast period.
Market Trends/Key Takeaways
The demand for ready-to-use bioassay banks has significantly increased. Ready-to-use bioassay banks are used in situations where cells are used straight from the vial in the bioassay, thereby eliminating theย cell expansionย step. Ready-to-use bioassay banks are typically large in size, commonly ranging between 400-1000 vials and have large cell densities per vial.
Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in January 2020, Charles River Laboratories International, Inc. acquired HemaCare Corporation for around US$ 380 million in cash.
๐๐๐ญ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐๐ฉ๐จ๐ซ๐ญ: (๐๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐, ๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐๐ฅ๐๐ฌ & ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ, ๐๐ก๐๐ซ๐ญ) @ https://www.coherentmarketinsights.com/insight/request-pdf/3634
Regulations
U.S.
Section 501(a)(2)(B) of the FD&C Act; 21 CFR parts 210 and 211; and 21 CFR part 600
- All manufacturing facilities to ensure compliance with cGMP regulations
- cGMP includes the implementation of oversight and controls over the manufacture of drugs to ensure quality, including managing the risk of and establishing the safety of raw materials, materials used in the manufacturing of drugs, and finished drug products.
21 CFR 211.22(d)
- Requirement of the quality unit of a pharmaceutical company to monitor adherence to regulations by a CMO
- When a pharmaceutical company uses a contract facility, their quality unit is legally responsible for approving or rejecting drug products manufactured by the contract facility, including for final release. The regulations require that the quality unitโs responsibilities and procedures be in writing and that they be followed. Quality agreements should clearly describe the materials or services to be provided, quality specifications, and communication mechanisms between the owner and contract facility.
Global GMP Cell Banking Services Market: Competitive Landscape ย
Major players operating in the global GMP cell banking services market include, WuXi AppTec Group, Charles River Laboratories International, Inc., Eurofins Scientific, Merck KGaA, Lonza Group Ltd., SGS Ltd., ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., and Paragon Bioservices, Inc.
Global GMP Cell Banking Services Market: Key Developmentsย ย
Major players in the market are focused on adopting collaboration strategies to expand their product portfolio. For instance, in March 2020, Lonza collaborated with Stanford University School of Medicine, Fred Hutchinson Cancer Research Center, and Parker Institute for Cancer Immunotherapy for R&D in cell therapy.
Major players in the market are also focused on adopting various marketing strategies to expand their customer base. For instance, in January 2020, Charles River Laboratories International, Inc. presented at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, California, U.S.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ญ๐ก ๐ ๐ฅ๐๐ญ ๐๐๐ ๐๐๐๐ ๐๐ ๐ @ https://www.coherentmarketinsights.com/promo/buynow/3634
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Cell Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product launch
- PEST Analysis
- Regulatory Scenario
- Mergers and Acquisitions
- Market Dynamics
- Global GMP Cell Banking Services Market, By Cell Type, 2019 โ 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 โ 2027
- Segment Trends
- Mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Mn)
- Microbial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Mn)
- Insect
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Mn)
- Yeast
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Mn)
- Avian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Mn)
- Stem Cell Type
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Mn)
- Introduction
- Global GMP Cell Banking Services Market, By End User, 2019 โ 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 โ 2027
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Mn)
- Contract Manufacturing Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Mn)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/gmp-cell-banking-services-market-2929
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837